How to Make the Most of MAP
Andy Rawson
Country Manager
Dompé UK Ltd
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
Qualification To Present On Map?
Big Pharma To Start Up
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
MAKING THE MOST OF MAP
A Bit Like ‘Who Wants To Be A Millionaire?’
Christian
Mark
Samir
Chris
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
Current Trending
Topics
‘What’s Hot?’
Keep clicking on
topic links…
MAP FOR PROVISION OF INFORMATION
All You Ever Needed To Know About Market Access, But Never Asked When You Should
Have!
•
Product regulation, pricing, national reimbursement and NHS Funding stream
•
Public affairs
•
News articles on the latest market access topics for each country
•
Direct web links from topic page being studied to relevant Govt policy, publication or
directive
•
MAP publications
•
Market Access Consultancy
•
Market Access Tools
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
MAP FOR PROVISION OF TOOLS
Off The Shelf Tools With Which To Help Access Challenges
•
Easy to access, helpful tools
–
Downloadable from the site
–
Heavily subsidised for subscribers
–
Cost saving, but relevant for need
•
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
Easy to follow posters
–
Downloadable from the site
–
Free for subscribers
–
Quick overview of market access in
each country
MAP IN THE UK
A Personal Experience
Making the Most of…
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
MAP UK SECTION
Easy Access & Navigation
•
Very simple, easily navigable landing home page
–
•
•
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
Content is clearly defined (no ambiguity)
Each MAP country section covers the main market access issues
–
Market Access Overview
–
Decision Makers
–
Government Affairs Strategy
–
Pricing
–
Reimbursement
Each section then drills down into more in depth information
and guidance with a series of clicks as appropriate
FROM SIMPLICITY TO DETAIL
Unravelling Funding And Market Access
•
MAP outlines the main bodies you will encounter in
each country with:
–
links to the stakeholder’s website for further
information
–
one line summaries of each stakeholder
Horizon Scanning Research & Intelligence Centre (HSRIC)
Stakeholders Overview
Flowcharts for every country outlining the
organisational structure of key stakeholders
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
EDUCATION AND FILLING THE GAPS
New Product Introduction: Process And Requirements To Plan Ahead
Simple
Depth
Addressing
barriers
Deeper
And Opportunity to
search in greater
depth
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
FLOW CHARTS AND DIAGRAMS
Simple Diagrams giving a
macro view…
…To greater complexity which help
educate others on challenges in UK
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
PRICING
UK PPRS
PPRS FAQ
• Relevant sections for companies such
as:
–
How to get or increase a price under
the PPRS
•
–
Comprehensive FAQ section of
questions asked by subscribers
•
–
Including a template letter to send to
the DH PPRS team
Covering hot topics within the PPRS
e.g. modulation
Validated by key regulatory bodies
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
…AND THERE’S MORE
Hot Topics
Specialised services in Wales
•
MAP monitor all market access issues, and update
their site regularly to reflect changes and issues
which will affect us as an industry
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
…AND FINALLY
MAP Europe
•
Everyone has access to MAP Europe
which covers market access aspects that
are applicable to all countries such as:
–
European country overviews
–
Product licensing and regulations
–
Early access schemes (PRIME,
Compassionate use etc.)
–
International Reference Pricing
–
Tenders
–
Orphan treatments
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
...IN SUMMARY
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.
www.dompe.com
© 2015 Dompé farmaceutici S.p.A. All rights reserved. Confidential and proprietary.